Newsfeeds - Spark Newswire

2 minute read

PureTechFounded Entity Akili Announces Topline Results From Shionogi Phase 2 Study In Japan

September 29, 8:08 AM

Shionogi successfully completes first-ever clinical study of Akili's video game-based cognitive treatment outside of the U.S.; plans to advance technology to the next step Data show Akili's digital treatment was

PRTC

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

August 30, 12:36 PM

ABSI

1 minute read

SVB Leerink Maintains Outperform on PureTech Health, Raises Price Target to $76

By Benzinga Newsdesk

August 25, 4:41 AM

SVB Leerink analyst Thomas Smith maintains PureTech Health (NASDAQ:PRTC) with a Outperform and raises the price target from $74 to $76.

PRTC

2 minute read

Earnings Scheduled For August 24, 2021

By Benzinga Insights

August 24, 4:29 AM

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is likely to report earnings for its second quarter.

AAP

1 minute read

Imbrium Therapeutics To Develop PureTech’s Non-Opioid Candidate For Chronic Bladder Condition

By Vandana Singh

August 11, 2:25 PM

Imbrium Therapeutics has exercised a license option to develop PureTech Health plc’s (NASDAQ:PRTC) LYT-503/IMB-150 (formerly designated as ALV-107), a non-opioid therapeutic candidate for…

PRTC

2 minute read

PureTech Health Reports Imbrium Therapeutics Exercised License Option Under R&D Collab For LYT-503/IMB-150 For Interstitial Cystitis/Bladder Pain Syndrome; PureTech Receives $6.5M, Is Eligible For Added $53M In Milestones

By Benzinga Newsdesk

August 11, 7:20 AM

Imbrium Therapeutics has paid PureTech $6.5 million and PureTech is eligible to receive up to $53 million in additional development milestone payments for this program in addition to royalties on product sales Imbrium

PRTC

2 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

July 15, 12:45 PM

AMEH

1 minute read

General

PureTech And Qualcomm Announce Collaboration To ‘optimize use of Sonde’s vocal biomarker technology’ On The Qualcomm Snapdragon 888 And 778G 5G Mobile Platforms

By Bill Haddad

July 8, 9:10 AM

PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)))) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, is pleased to note that its Founded Entity, Sonde Health

PRTC

1 minute read

PureTech Health To Test LYT-200 / Tislelizumab Combo In Difficult To Treat Cancer

By Vandana Singh

July 7, 11:30 AM

PureTech Health plc (NASDAQ:PRTC) has announced a clinical trial and supply agreement with an affiliate of BeiGene Ltd (NASDAQ:BGNE). The partnership will evaluate…

BGNE

3 minute read

News

PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors

By Benzinga Newsdesk

July 7, 7:05 AM

PureTech Health plc (NASDAQ:PRTC, LSE: PRTC)) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated

BGNE